JPRN-UMIN000026173已完成4 期
Early anti-VEGF Therapy Intervention for Retinal Vein Occlusion - Early anti-VEGF Therapy Intervention for RVO
Kyoto Prefectural Univerisity of Medicine0 个研究点目标入组 50 人开始时间: 2017年2月16日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. prior laser treatment, surgery, local steroid injection or anti-VEGF drug administration 2. bilateral retinal vein occlusion 3. uncontrolled glaucoma 4. uncontrolled systemic hypertension 5. other retinal disorders
研究者
相似试验
已完成
不适用
Intravitreal anti-VEGF Therapies for Macular Edema Folowing Retinal Vein OcclusioRetinal vein occlusionJPRN-UMIN000023005Kawasaki Medical School33
招募中
不适用
Intravitreal anti-VEGF therapies for macular edema folowing age-related macular degeneratioage-related macular degenerationJPRN-UMIN000023676Kawasaki Medical School500
已完成
不适用
Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGFRetinal NeovascularizationNCT02876198Fondation Ophtalmologique Adolphe de Rothschild74
撤回
2 期
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)Retinopathy of PrematurityNCT01232777Vision Research Foundation
进行中（未招募）
早期 1 期
VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization DiseasesNeovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein OcclusionNCT05099094Shanghai BDgene Co., Ltd.3